BIO Bionostics

RNS Number:7700G
Bionostics PLC
31 October 2007


                                                                        FORM 8.1
          DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES
                  FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
                 (Rules 8.1(a) and (b)(i) of the Takeover Code)

1. KEY INFORMATION

Name of person dealing (Note 1)                  MICHAEL H. THOMAS
Company dealt in                                 BIONOSTICS PLC
Class of relevant security to which              
the dealings being disclosed relate (Note 2)     25P ORDINARY SHARES
Date of dealing                                  30 OCTOBER 2007


2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)

                                                      Long                       Short
                                                Number     (%)             Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total


(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)

Class of relevant security:                            Long                       Short
                                                Number     (%)             Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total


(c) Rights to subscribe (Note 3)

Class of relevant security:          Details


3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale                  Number of securities          Price per unit (Note 5)


(b) Derivatives transactions (other than options)

Product name,     Long/short (Note 6)   Number of securities (Note 7)   Price per unit (Note 5)
e.g. CFD                               



(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying

Product name,    Writing,      Number of         Exercise   Type, e.g.  Expiry   Option money
e.g. call        selling,      securities to     price      American,   date     paid/received
option           purchasing,   which the option             European             per unit
                 varying       relates (Note 7)             etc.                 (Note 5)
                 etc.


(ii) Exercising

Product name, e.g. call option       Number of securities          Exercise price per unit (Note 5)
                                                     
BIONOSTICS PLC SHARE AWARDS          50,000                        NIL


(d) Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8)      Details                       Price per unit (if applicable) (Note 5)


4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any
option referred to on this form or relating to the voting rights or future acquisition or
disposal of any relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.


Is a Supplemental Form 8 attached? (Note 9)      YES/NO

Date of disclosure                               31 OCTOBER 2007

Contact name                                     KELLY WINN

Telephone number                                 1993 885070

Name of offeree/offeror with which associated    BIONOSTICS PLC

Specify category and nature of associate status 
(Note 10)                                        DIRECTOR


Notes

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
DCCWUGAUUUPMGMG

Grafico Azioni Biofocus (LSE:BIO)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Biofocus (LSE:BIO)
Storico
Da Giu 2023 a Giu 2024